{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:03:41Z","timestamp":1788433421833,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.neuro.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:21:20Z","timestamp":1563618080000},"page":"172-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-\u03baB and \u03b1-synuclein expressions in mice"],"prefix":"10.1016","volume":"74","author":[{"given":"Akinyinka O.","family":"Alabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi M.","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benneth","family":"Ben-Azu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale G.","family":"Bakre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-5111","authenticated-orcid":false,"given":"Solomon","family":"Umukoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2019.07.003_bib0005","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.13087","article-title":"Neuroprotective effects of vildagliptin in rat rotenone Parkinson\u2019s disease model: role of RAGE-NF\u03baB and Nrf2-antioxidant signaling pathways","volume":"133","author":"Abdelsalam","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav.Brain Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0015","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1007\/s12035-017-0855-1","article-title":"Neuroprotective effects of filgrastim in rotenone-induced Parkinson\u2019s disease in rats: Insights into its anti-inflammatory, neurotrophic, and antiapoptotic effects","volume":"55","author":"Azmy","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0020","first-page":"S572","article-title":"Toxicologic and dermatologic assessment of cyclopentanones and cyclopentenones when used as fragrance ingredients","volume":"50","author":"Belsito","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.neuro.2019.07.003_bib0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nbd.2010.03.006","article-title":"Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study","volume":"38","author":"Blesa","year":"2010","journal-title":"Neurobiol. Disease"},{"key":"10.1016\/j.neuro.2019.07.003_bib0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1146\/annurev.bi.59.070190.004301","article-title":"Defense-related proteins in higher plant","volume":"59","author":"Bowles","year":"1990","journal-title":"Ann Rev Biochemistr"},{"key":"10.1016\/j.neuro.2019.07.003_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2006.01.008","article-title":"Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice","volume":"1762","author":"Casadesus","year":"2006","journal-title":"Biochim.Biophys.Acta"},{"key":"10.1016\/j.neuro.2019.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/572097","article-title":"Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis","volume":"2014","author":"Cesari","year":"2014","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2019.07.003_bib0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12031-015-0547-0","article-title":"Naringin abrogates cisplatin-induced cognitive defcits and cholinergic dysfunction through the down-regulation of AChE expression and iNOS signaling pathways in hippocampus of aged rats","volume":"56","author":"Chtourou","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuro.2019.07.003_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2018.09.001","article-title":"\u03b1-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson\u2019s disease","volume":"310","author":"Cooper","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0060","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1016\/j.bmc.2008.10.050","article-title":"New jasmonate analogues as potential anti-inflammatory agents","volume":"16","author":"Dang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuro.2019.07.003_bib0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2019.07.003_bib0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuro.2019.07.003_bib0075","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s11064-016-1901-5","article-title":"Vanillin attenuated behavioural impairments, neurochemical deficts, oxidative stress and apoptosis against rotenone induced rat model of Parkinson\u2019s disease","volume":"41","author":"Dhanalakshmi","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0080","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s11064-016-2050-6","article-title":"Possible methyl mechanisms involved in attenuation of lipopolysaccharide-induced memory deficits by jasmonate in mice","volume":"41","author":"Eduviere","year":"2016","journal-title":"Neurochemical. Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid, colorimetric determination of acetyl-cholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem.Pharmacol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0090","first-page":"22789","article-title":"Methyl jasmonate: exemption from the requirement of a tolerance","volume":"78","author":"Environmental Protection Agency (EPA)","year":"2013","journal-title":"Fed.Regist."},{"key":"10.1016\/j.neuro.2019.07.003_bib0095","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/IJN.S93918","article-title":"Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson\u2019s disease models","volume":"10","author":"Ganesan","year":"2015","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.neuro.2019.07.003_bib0100","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NFkappa B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuro.2019.07.003_bib0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.6451927","article-title":"Nitrate synthesis in the germ free and conventional rat","volume":"212","author":"Green","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neuro.2019.07.003_bib0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0270(99)00035-7","article-title":"An unsteady platform test for measuring static equilibrium in mice","volume":"88","author":"Hilber","year":"1999","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuro.2019.07.003_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"l8","author":"Hirsch","year":"2009","journal-title":"Lancet Neuro"},{"key":"10.1016\/j.neuro.2019.07.003_bib0120","article-title":"Dopamine receptors and parkinson\u2019s disease","author":"Hisahara","year":"2011","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J. Neurochemist."},{"key":"10.1016\/j.neuro.2019.07.003_bib0130","first-page":"1242","article-title":"Fragrances in oolong that enhance the response of GABAAreceptors","volume":"68","author":"Hossain","year":"2004","journal-title":"Biosci. Biochnol. Biochem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neurosci."},{"issue":"Suppl. 3","key":"10.1016\/j.neuro.2019.07.003_bib0140","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0145","first-page":"1233","article-title":"Methyl jasmonate induces apoptosis through induction of Bax\/Bcl-XS and activation of caspase-3 via ROS production in A549 cells","volume":"12","author":"Kim","year":"2004","journal-title":"Oncol. Reports"},{"key":"10.1016\/j.neuro.2019.07.003_bib0150","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1023207222944","article-title":"Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists","volume":"28","author":"Kitamura","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.1994.tb21807.x","article-title":"Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum","volume":"738","author":"Kondo","year":"1994","journal-title":"Ann. N. Y.Acad. Sci."},{"key":"10.1016\/j.neuro.2019.07.003_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00421-005-1402-8","article-title":"Sedative effects of the jasmine tea odor and (R)-(\u2212)-linalool, one of its major odor components on autonomic nerve activity and mood states","volume":"95","author":"Kuroda","year":"2005","journal-title":"Eur. J. Appl. Physiol. Occup. Physiol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson\u2019s disease","volume":"25","author":"Lastres\u2010Becker","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.neuro.2019.07.003_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00109-010-0688-0","article-title":"Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-\u03baB pathway","volume":"89","author":"Lee","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neuro.2019.07.003_bib0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-008-0134-4","article-title":"DJ\u20101 protects against dopamine toxicity","volume":"116","author":"Lev","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2019.07.003_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4161\/cc.4.2.1490","article-title":"c-Abl in oxidative stress, aging and cancer","volume":"4","author":"Li","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuro.2019.07.003_bib0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2008.03.004","article-title":"Bromocriptine activates NQO1 via Nrf2-PI3K\/Akt signaling: novel cytoprotective mechanism against oxidative damage","volume":"57","author":"Lim","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0190","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon- deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2019.07.003_bib0195","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantianigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2019.07.003_bib0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett. Suppl."},{"key":"10.1016\/j.neuro.2019.07.003_bib0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett. Suppl."},{"issue":"5","key":"10.1016\/j.neuro.2019.07.003_bib0210","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"Morais","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuro.2019.07.003_bib0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. BiophysActa"},{"key":"10.1016\/j.neuro.2019.07.003_bib0220","doi-asserted-by":"crossref","first-page":"21212","DOI":"10.1074\/jbc.M412621200","article-title":"Reversible inhibition of alpha-synucleinfibrillization by dopaminochrome-mediated conformational alterations","volume":"280","author":"Norris","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0225","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuro.2019.07.003_bib0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(94)90969-5","article-title":"Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro","volume":"657","author":"Ogawa","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biopha.2017.12.098","article-title":"Jobelyn\u00ae attenuates inflammatory responses and neurobehavioural deficits associated with complete Freund-Adjuvant-induced arthritis in mice","volume":"98","author":"Omorogbe","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuro.2019.07.003_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14715\/cmb\/2016.62.14.2","article-title":"Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson\u2019s disease through regulating Keap1\/Nrf2 signaling pathway","volume":"62","author":"Pan","year":"2016","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.neuro.2019.07.003_bib0250","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantianigra in Parkinson\u2019s disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.neuro.2019.07.003_bib0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2019.07.003_bib0260","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1016\/j.neuro.2019.07.003_bib0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","article-title":"Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy","volume":"117","author":"Qian","year":"2010","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuro.2019.07.003_bib0270","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0302-2838(02)00054-4","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson\u2019s disease","volume":"41","author":"Raffaele","year":"2002","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0275","first-page":"1854","article-title":"Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochrondria","volume":"65","author":"Roteim","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuro.2019.07.003_bib0280","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuro.2019.07.003_bib0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","article-title":"Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance","volume":"468","author":"Scalzo","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2019.07.003_bib0290","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2019.07.003_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1353-8020(00)00079-1","article-title":"Longitudinal evaluation of economic and physical impact of Parkinson\u2019s disease","volume":"8","author":"Schenkman","year":"2001","journal-title":"ParkinsonismRelat. Disord."},{"key":"10.1016\/j.neuro.2019.07.003_bib0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behavioural. Brain Res."},{"issue":"6","key":"10.1016\/j.neuro.2019.07.003_bib0305","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00045415-200211000-00005","article-title":"Fibrotic valvular heart disease subsequent to bromocriptine treatment","volume":"10","author":"Serratrice","year":"2002","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.neuro.2019.07.003_bib0310","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson\u2019s disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2019.07.003_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0320","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders a\ufb00 ;ecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2010.03.019","article-title":"A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats","volume":"272","author":"Swarnkar","year":"2010","journal-title":"Toxicol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0330","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","article-title":"Peroxynitrite: biochemistry, pathophysiology and development of therapeutics","volume":"6","author":"Szabo","year":"2007","journal-title":"Nature Rev. Drug Disc."},{"key":"10.1016\/j.neuro.2019.07.003_bib0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.1999.7122","article-title":"Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors","volume":"159","author":"Takashima","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0340","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainresbull.2017.04.002","article-title":"Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice","volume":"131","author":"Umukoro","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.neuro.2019.07.003_bib0350","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1471-4159.2002.01224.x","article-title":"Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells","volume":"83","author":"Wang","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0355","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease","volume":"150","author":"Whitton","year":"2007","journal-title":"British J. Pharmacol."},{"key":"10.1016\/j.neuro.2019.07.003_bib0360","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","article-title":"In\ufb02ammatory response in Parkinson\u2019s disease","volume":"10","author":"Yan","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuro.2019.07.003_bib0365","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuint.2009.09.010","article-title":"NFkappa B mediates MPP+ induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun\/AP-1","volume":"56","author":"Yang","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuro.2019.07.003_bib0370","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1471-4159.1994.62031034.x","article-title":"Antioxidant properties of bromocriptine, a dopamine agonist","volume":"62","author":"Yoshikawa","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2019.07.003_bib0375","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","article-title":"Glutathione and Parkinson\u2019s disease: is this the elephant in the room?","volume":"62","author":"Zeevalk","year":"2008","journal-title":"Biomed. Pharmacother."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X19300701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X19300701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:21:06Z","timestamp":1758982866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X19300701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":75,"alternative-id":["S0161813X19300701"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2019.07.003","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-\u03baB and \u03b1-synuclein expressions in mice","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}